Gilteritinib-based combination therapy in adult relapsed/refractory FLT3-mutated acute myeloid leukaemia.
Chen N, Pan J, Zhou Y, Mao L, Lou Y, Qian J, Xu G, Wei J, Zhou D, Shou L, Huang L, Yan M, Zeng H, Fan C, Wu G, Feng W, Tong H, Jin J, Wang H.
Chen N, et al. Among authors: zeng h.
Br J Haematol. 2024 Mar;204(3):861-870. doi: 10.1111/bjh.19182. Epub 2023 Nov 8.
Br J Haematol. 2024.
PMID: 37939390